COVID vaccine rollout for U.S. children close after CDC panel vote

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

Register now for FREE unlimited access to Reuters.com

WASHINGTON, June 18 (Reuters) – The US Centers for Disease Control and Prevention on Saturday recommended COVID-19 vaccines for children as young as 6 months, allowing a nationwide rollout to start next week.

The CDC’s move came after a panel of advisers to the institution voted earlier on Saturday to recommend COVID-19 vaccines for children as young as six months.

“We know millions of parents and caregivers are eager to get their young children vaccinated, and with today’s decision, they can,” said Rochelle Walensky, the CDC director, in a statement.

Register now for FREE unlimited access to Reuters.com

The US Food and Drug Administration on Friday authorized Moderna Inc’s (MRNA.O) shot for children aged six months to 5 years, and Pfizer-BioNTech’s (PFE.N), vaccine for children aged six months to 4 years. Pfizer’s vaccine is already authorized for children over the age of 5. read more

“This infection kills children and we have an opportunity to prevent that,” Beth Bell, one of the doctors on the advisory panel, said following the vote. “Here is an opportunity to prevent a known risk.”

President Joe Biden’s administration plans to roll out the vaccines to the under-5 age groups as early as next week.

“This coming week, parents will be able to start scheduling appointments at places like pediatricians’ offices, children’s hospitals, and pharmacies,” Biden said in a statement on Saturday.

“Appointments will ramp up as more doses are shipped out, and in the coming weeks, every parent who wants a vaccine will be able to get one. As the vaccination program ramps up, Vaccines.gov will be live next week with vaccine availability and appointments increasing throughout the week.”

While many parents in the United States are eager to vaccinate their children, it is unclear how strong demand will be for the shots. The Pfizer-BioNTech vaccine was authorized for children aged 5 to 11 in October, but only about 29% of that group is so far fully vaccinated, federal data shows.

CVS Health Corp (CVS.N) plans to provide vaccines to children aged 18 months and older while Rite Aid Corp (RAD.N) and Walmart Inc (WMT.N) plan to offer these shots for kids who are at least 3 years old . Infants are traditionally vaccinated at a doctor’s office.

Public health officials have been pushing for childhood vaccinations ahead of the new as they hope shots the age group will help prevent hospitalizations for school years and deaths if COVID-19 cases rise again.

COVID-19 is generally more mild in children. Still, since March 2020 it has been the fifth leading cause of death in children aged 1-4 and the fourth leading cause of death in children younger than one, according to the CDC.

The CDC advisers will meet again next week to consider whether to back use of the Moderna vaccine for children and adolescents aged 6-17. There has been some concern about the rate of rare cases of heart inflammation in teenage boys and young men from the Moderna vaccine, and the advisers are expected to consider that data.

Register now for FREE unlimited access to Reuters.com

Additional Reporting by Leroy Leo, Manas and Jaiveer Singh Shekhawat in Bengaluru; Editing by Paul Simao and Franklin Paul

Our Standards: The Thomson Reuters Trust Principles.

.

Leave a Comment